Home / Health / IAP Bans Infant Formula Company Sponsorships
IAP Bans Infant Formula Company Sponsorships
6 Dec
Summary
- IAP directs members not to engage with infant formula sponsors.
- Doctors must obtain undertakings from sponsors regarding IMS Act compliance.
- IAP prioritizes breastfeeding and children's health interests.
The Indian Academy of Paediatrics (IAP), representing 47,000 members nationwide, has issued a strong directive on November 27th, urging its members to cease involvement in any activities sponsored by companies that contravene the Infant Milk Substitutes (IMS) Act. This proactive measure aims to uphold the principles of the Act, which strictly regulates the production, supply, and distribution of infant milk substitutes.
The IAP has emphasized that its members must avoid any direct or indirect collaboration with firms producing or distributing infant milk substitutes, infant foods, or feeding bottles. To ensure compliance, paediatricians are required to obtain formal written assurances from sponsors, confirming their non-involvement in products falling under the IMS Act's purview.
Dr. Vasant Khalatka, president of IAP, stated that paediatricians are dedicated to promoting breastfeeding and acting in the best interests of children's health and public health. The organization has also provided an updated list of companies involved in these regulated products, reinforcing its commitment to transparency and adherence to the law.
